Waldenström's macroglobulinemia classification: Difference between revisions

	Waldenström's macroglobulinemia Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Waldenström's macroglobulinemia from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Bone Marrow Aspiration and Biopsy
Electrophoresis and Immunofixation
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Waldenström's macroglobulinemia classification On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Waldenström's macroglobulinemia classification All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Waldenström's macroglobulinemia classification
CDC on Waldenström's macroglobulinemia classification
Waldenström's macroglobulinemia classification in the news
Blogs on Waldenström's macroglobulinemia classification
Directions to Hospitals Treating Waldenström's macroglobulinemia
Risk calculators and risk factors for Waldenström's macroglobulinemia classification

← Older edit

VisualWikitext

Latest revision as of 19:23, 30 July 2020

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Mohsin, M.D.[2], Roukoz A. Karam, M.D.[3]; Grammar Reviewer: Natalie Harpenau, B.S.[4]

Overview

There is no established system for the classification of Waldenstrom's macroglobulinemia. However, according to a devised criteria based upon patient's symptoms, Waldenström's macroglobulinemia can be further classified into smoldering/asymptomatic and symptomatic WM.

Classification

There is no established system for the classification of Waldenstrom's macroglobulinemia. However, according to a devised criteria based upon patient's symptoms, Waldenström's macroglobulinemia can be further classified into:^[1]

Symptomatic Waldenstrom macroglobulinemia
Asymptomatic/Smoldering Waldenstrom macroglobulinemia (SWM)^[2]

**Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders**
Criteria	Symptomatic WM	Asymptomatic WM	IgM-Related Disorders	MGUS
IgM monoclonal protein	+	+	+	+
Bone marrow infiltration	+	+	-	-
Symptoms attributable to IgM	+	-	+	-
Symptoms attributable to tumor infiltration	+	-	-	-

References

↑ Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005). "Diagnosis and management of Waldenstrom's macroglobulinemia". J Clin Oncol. 23 (7): 1564–77. doi:10.1200/JCO.2005.03.144. PMID 15735132.
↑ Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M; et al. (2003). "Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia". Semin Oncol. 30 (2): 116–20. doi:10.1053/sonc.2003.50038. PMID 12720119.

Template:WH Template:WS

[pmid15735132-1] Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP (2005). "Diagnosis and management of Waldenstrom's macroglobulinemia". J Clin Oncol. 23 (7): 1564–77. doi:10.1200/JCO.2005.03.144. PMID 15735132.

[pmid12720119-2] Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M; et al. (2003). "Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia". Semin Oncol. 30 (2): 116–20. doi:10.1053/sonc.2003.50038. PMID 12720119.

[1]

[2]

@@ Line 1: / Line 1: @@
 __NOTOC__
 {{Waldenström's macroglobulinemia}}
-Please help WikiDoc by adding content here.  It's easy!  Click  [[Help:How_to_Edit_a_Page|here]]  to learn about editing.
+{{CMG}}; {{AE}} {{S.M.}}, {{RAK}}; {{GRR}} {{Nat}}
+==Overview==
+There is no established [[system]] for the [[classification]] of [[Waldenström's macroglobulinemia|Waldenstrom's macroglobulinemia]]. However, according to a devised [[criteria]] [[Based on Symptoms|based upon patient's symptoms]], [[Waldenström's macroglobulinemia]] can be further [[Classification|classified]] into smoldering/[[asymptomatic]] and [[symptomatic]] [[Waldenström's macroglobulinemia|WM]].
+==Classification==
+There is no established [[system]] for the [[classification]] of [[Waldenström's macroglobulinemia|Waldenstrom's macroglobulinemia]]. However, according to a devised [[criteria]] [[Based on Symptoms|based upon patient's symptoms]], [[Waldenström's macroglobulinemia]] can be further [[Classification|classified]] into:<ref name="pmid15735132">{{cite journal| author=Dimopoulos MA, Kyle RA, Anagnostopoulos A, Treon SP| title=Diagnosis and management of Waldenstrom's macroglobulinemia. | journal=J Clin Oncol | year= 2005 | volume= 23 | issue= 7 | pages= 1564-77 | pmid=15735132 | doi=10.1200/JCO.2005.03.144 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=15735132  }} </ref>
+*[[Symptomatic]] [[Waldenstrom macroglobulinemia]]
+*[[Asymptomatic]]/Smoldering [[Waldenstrom macroglobulinemia]] (SWM)<ref name="pmid12720119">{{cite journal| author=Kyle RA, Treon SP, Alexanian R, Barlogie B, Björkholm M, Dhodapkar M et al.| title=Prognostic markers and criteria to initiate therapy in Waldenstrom's macroglobulinemia: consensus panel recommendations from the Second International Workshop on Waldenstrom's Macroglobulinemia. | journal=Semin Oncol | year= 2003 | volume= 30 | issue= 2 | pages= 116-20 | pmid=12720119 | doi=10.1053/sonc.2003.50038 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12720119  }} </ref>
+{|
+|+ '''Classification of Waldenstrom macroglobulinemia (WM) and Related Disorders'''
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Criteria
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Symptomatic WM
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |Asymptomatic WM
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |IgM-Related Disorders
+! style="background:#4479BA; color: #FFFFFF;" align="center" + |MGUS
+|-
+! align="center" style="background:#DCDCDC;" + |IgM monoclonal protein
+| style="background:#F5F5F5;" align="center" + | +
+| style="background:#F5F5F5;" align="center" + | +
+| style="background:#F5F5F5;" align="center" + | +
+| style="background:#F5F5F5;" align="center" + | +
+|-
+! align="center" style="background:#DCDCDC;" + |Bone marrow infiltration
+| style="background:#F5F5F5;" align="center" + | +
+| style="background:#F5F5F5;" align="center" + | +
+| style="background:#F5F5F5;" align="center" + | -
+| style="background:#F5F5F5;" align="center" + | -
+|-
+! align="center" style="background:#DCDCDC;" + |Symptoms attributable to IgM
+| style="background:#F5F5F5;" align="center" + | +
+| style="background:#F5F5F5;" align="center" + | -
+| style="background:#F5F5F5;" align="center" + | +
+| style="background:#F5F5F5;" align="center" + | -
+|-
+! align="center" style="background:#DCDCDC;" + |Symptoms attributable to tumor infiltration
+| style="background:#F5F5F5;" align="center" + | +
+| style="background:#F5F5F5;" align="center" + | -
+| style="background:#F5F5F5;" align="center" + | -
+| style="background:#F5F5F5;" align="center" + | -
+|}
 ==References==
@@ Line 9: / Line 50: @@
 {{WS}}
-[[Category:Needs content]]
 [[Category:Disease]]
 [[Category:Blood]]
 [[Category:Hematology]]

Waldenström's macroglobulinemia classification: Difference between revisions

Latest revision as of 19:23, 30 July 2020

Overview

Classification

References

Navigation menu

Search